Clinical Trial: Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal Seizures

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923734) titled 'Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal Seizures' on Oct. 13.

Brief Summary: This Phase 4, multicenter, single-arm, open-label study evaluates the effect of intravenous Sezaby (phenobarbital sodium) on electrocardiographic safety, including the QT interval, in neonates with seizures.

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Neonatal Seizure

Intervention: DRUG: Sezaby

Sezaby (phenobarbital sodium for injection) is administered as intravenous loading and maintenance doses over a treatment period of up to 5 days for the treatment of neonatal seizures.

Recruitment Status: NOT_YET_RE...